Models for Predicting Type 1 Diabetes in Siblings of Affected Children
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—To generate predictive models for the assessment of risk of type 1 diabetes and age at diagnosis in siblings of children with newly diagnosed type 1 diabetes. RESEARCH DESIGN AND METHODS—Cox regression analysis was used to assess the risk of progression to type 1 diabetes, and multiple regression analysis was used to estimate the age at disease presentation in 701 siblings of affected children. Sociodemographic, genetic, and immunological variables were included in the analyses. Subanalyses were performed in a group of 77 autoantibody-positive siblings with additional metabolic data. RESULTS—A total of 47 siblings (6.7%) presented with type 1 diabetes during the 15-year observation period. Young age, an increasing number of detectable diabetes-associated autoantibodies at initial sampling and of affected first-degree relatives, and HLA DR–conferred disease susceptibility predicted progression to type 1 diabetes. In the subgroup of 77 autoantibody-positive siblings, young age, HLA DR–conferred susceptibility, an increasing number of autoantibodies, a reduced first-phase insulin response, and decreased insulin sensitivity in relation to first-phase insulin response were associated with increased risk of progression to type 1 diabetes. Age at diagnosis was predicted by age, insulinoma-associated protein 2 antibody levels, and number of autoantibodies at initial sampling (R2 = 0.76; P < 0.001). In the smaller cohort of autoantibody-positive subjects, first-phase insulin response and HLA DR–conferred susceptibility were additional predictors of age at diagnosis. CONCLUSIONS—Information on autoantibody status and levels, HLA-conferred disease susceptibility, and insulin secretion and sensitivity seems to be useful in addition to age and family history of type 1 diabetes when assessing risk of progression to type 1 diabetes and time to diagnosis in siblings of children with newly diagnosed type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · cited 1×
“99) with the newer HOMA computer model (17).”
MethodISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Singal, D. P., & Blajchman, M. A. (1973) · Diabetes · doi:10.2337/diab.22.6.429 · Cited by 412
Kimpimäki, T., Kulmala, P., Savola, K., Kupila, A., Korhonen, S., Simell, T., Ilonen, J., Simell, O., & Knip, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020018 · Cited by 146 · cited 1×
“IA-2As have been reported to appear in most cases as the last autoantibody during the pre-diabetic disease process (23,24), and they have also been observed to be the most predictive autoantibodies among first-degree relatives (10,25).”
BackgroundSelf-citation
Cited by
Libman, I., Haynes, A., Lyons, S., Pradeep, P., Rwagasor, E., Tung, J. Y., Jefferies, C. A., Oram, R. A., Dabelea, D., & Craig, M. E. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13454 · Cited by 285
Redondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216
“children of a female patient and 6% to 9% in children of a male patient.(15,16) While the risk of T1D in non-identical twins is similar to”
BackgroundEarly prediction of autoimmune (type 1) diabetes.
Regnell, S. E., & Lernmark, Å. (2017) · Diabetologia · doi:10.1007/s00125-017-4308-1 · Cited by 195
Steck, A. K., Johnson, K., Barriga, K. J., Miao, D., Yu, L., Hutton, J. C., Eisenbarth, G. S., & Rewers, M. J. (2011) · Diabetes Care · doi:10.2337/dc10-2088 · Cited by 195
“9 years, 76% of the variance in the age at diagnosis was explained by age at first sampling, initial IA-2 level, and initial number of detectable autoantibodies (11).”
BackgroundResultSteck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2426 · Cited by 185
Self-citation
Metadata
- Authors
- Mrena, S., Virtanen, S. M., Laippala, P., Kulmala, P., Hannila, M.-L., Åkerblom, H. K., Knip, M., & the Childhood Diabetes in Finland Study Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-03-01
- Volume
- 29
- Issue
- 3
- Pages
- 662-667
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2105271024
- Cited by
- 97
- References
- 6
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Models for Predicting Type 1 Diabetes in Siblings of Affected Children. https://app.cochat.ai/papers/10.2337/diacare.29.03.06.dc05-0774
- The paper
- Mrena, S., Virtanen, S. M., Laippala, P., Kulmala, P., Hannila, M.-L., Åkerblom, H. K., Knip, M., & the Childhood Diabetes in Finland Study Group. (2006). Models for Predicting Type 1 Diabetes in Siblings of Affected Children. Diabetes Care. https://doi.org/10.2337/diacare.29.03.06.dc05-0774
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.